Retropharyngeal abscess as a paradoxical reaction in a child with multi-drug-resistant tuberculosis

被引:6
|
作者
Desai, Lavina [1 ]
Shah, Ira [2 ]
Shaan, Manohar [3 ]
机构
[1] King Edward Mem Hosp, Seth GS Med Coll, Bombay, Maharashtra, India
[2] Nanavati Hosp, Dept Pediat Infect Dis, Mumbai, Maharashtra, India
[3] Nanavati Hosp, Dept ENT, Mumbai, Maharashtra, India
关键词
Retropharyngeal abscess; tuberculous paradoxical reactions; paradoxical reactions in MDR-TB; retropharyngeal abscess in TB; retropharyngeal abscessas paradoxical reaction; IMMUNOCOMPETENT CHILDREN;
D O I
10.1080/20469047.2018.1518054
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Paradoxical reactions (PRs) are exaggerated inflammatory responses owing to recovery of cellular immunity following initiation of anti-tuberculous therapy (ATT). The presentation is worsening of pre-existing symptoms or development of new lesions. A 14-year-old girl with multi-drug-resistant tuberculosis developed a recurrent asymptomatic retropharyngeal abscess while on ATT. She required multiple aspirations of the abscess. Xpert MTB/RIF detected Mycobacterium tuberculosis from the aspirate which was resistant to rifampicin; culture was negative. Following aspirations of the abscess, continued ATT and a 2-month course of corticosteroids, she remains well and has gained weight. A retropharyngeal abscess presenting in the form of a PR has not been reported previously in adults or children.
引用
收藏
页码:287 / 289
页数:3
相关论文
共 50 条
  • [21] MULTI-DRUG-RESISTANT (MDR) TUBERCULOSIS (TB) COMPLICATED WITH EMPYEMA NECESSITANS (EN)
    Tangella, Nikita
    Nahar, Richa
    Suilon Ng
    Lardizabal, Alfred A.
    CHEST, 2023, 164 (04) : 4824A - 4824A
  • [22] Emergence and clonal transmission of multi-drug-resistant tuberculosis among patients in Chad
    Awa Ba Diallo
    Gedeon W. Ossoga
    Geraldine Daneau
    Seynabou Lo
    Richard Ngandolo
    Colette Diguimbaye Djaibé
    Barou Djouater
    Souleymane Mboup
    Bouke C. de Jong
    Aissatou G. Diallo
    Florian Gehre
    BMC Infectious Diseases, 17
  • [23] Molecular Indicator for Distinguishing Multi-drug-Resistant Tuberculosis from Drug Sensitivity Tuberculosis and Potential Medications for Treatment
    Song, Shulin
    Gan, Donghui
    Wu, Di
    Li, Ting
    Zhang, Shiqian
    Lu, Yibo
    Jin, Guanqiao
    MOLECULAR BIOTECHNOLOGY, 2024,
  • [24] Disinfectant-susceptibility of multi-drug-resistant Mycobacterium tuberculosis isolated in Japan
    Noriko Shinoda
    Satoshi Mitarai
    Eri Suzuki
    Mineo Watanabe
    Antimicrobial Resistance and Infection Control, 5
  • [25] MULTI-DRUG-RESISTANT BACTERIAL PATHOGENS
    TALLEY, R
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (13): : 1637 - 1637
  • [26] Disinfectant-susceptibility of multi-drug-resistant Mycobacterium tuberculosis isolated in Japan
    Shinoda, Noriko
    Mitarai, Satoshi
    Suzuki, Eri
    Watanabe, Mineo
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2016, 5
  • [27] Emergence and clonal transmission of multi-drug-resistant tuberculosis among patients in Chad
    Diallo, Awa Ba
    Ossoga, Gedeon W.
    Daneau, Geraldine
    Lo, Seynabou
    Ngandolo, Richard
    Djaibe, Colette Diguimbaye
    Djouater, Barou
    Mboup, Souleymane
    de Jong, Bouke C.
    Diallo, Aissatou G.
    Gehre, Florian
    BMC INFECTIOUS DISEASES, 2017, 17
  • [28] Multi-drug-resistant staphylococci and enterococci
    French, GL
    INFECTIONS IN THE CRITICALLY ILL: AN ONGOING CHALLENGE, 2001, : 113 - 119
  • [29] Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis
    Kamp, Jasper
    Bolhuis, Mathieu S.
    Tiberi, Simon
    Akkerman, Onno W.
    Centis, Rosella
    de lange, Wiel C.
    Kosterink, Jos G.
    van der Werf, Tjip S.
    Migliori, Giovanni B.
    Alffenaar, Jan-Willem C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (06) : 688 - 694
  • [30] DIHYDROSPHINGOSINE RELATED COMPOUNDS HIGHLY ACTIVE AGAINST MULTI-DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS
    del Olmo, Esther
    Bustos, Luis A.
    Lopez-Perez, Jose L.
    Molina-Salinas, Gloria M.
    Said-Fernandez, Salvador
    San Feliciano, Arturo
    DRUGS OF THE FUTURE, 2009, 34 : 181 - 181